BIVDA Press Releases

25Nov

Autumn Statement 2016: BIVDA’s Response

Commenting on the 2016 Autumn Statement, BIVDA’s Chief Executive Doris-Ann Williams MBE said:

“As the UK looks to establish its new place in the world following the outcome of the EU Referendum, we welcome the Government’s commitment to investment in research and development.

“This announcement sends a strong message that the UK takes its role as a leader in the life sciences seriously, and serves as a reminder that we are very much ‘open for business’.

“However, it’s important that along with an emphasis on R&D, attention is given to how we can increase the adoption of existing diagnostics across the NHS. We look forward to working with the Government over the coming months to ensure that this is a focus of the forthcoming industrial strategy and featured in the implementation of the Accelerated Access Review”.

Related

BIVDA Board elects Darren Stenlake as Chair

Darren Stenlake (Sysmex UK Ltd) has been elected as Chairman of the BIVDA Board

Read More >

Press Release - BIVDA welcomes approval of new COVID-19 vaccine

 BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 v...

Read More >

European Parliament endorses new Regulation on In Vitro Diagnostics

The European Parliament has endorsed the new Regulation on In Vitro Diagnostics (IVDR), a developmen...

Read More >

UK continues to lag behind the European market for in-vitro diagnostic expenditure

IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...

Read More >

BIVDA Press Release - BIVDA welcomes publication of NHS England diagnostics report

 BIVDA welcomes publication of NHS England diagnostics report.  BIVDA has warmly welcomed ...

Read More >

BIVDA Unveils New Website

The British In Vitro Diagnostics Association (BIVDA) has today unveiled its new website including a ...

Read More >